CD163 and neoplasm: While, the expression of CD163 in cancer cells of lymph node had no significant alteration compared with its expression in primary tumor cells, suggesting CD163 in cancer cells may not be a crucial risk for lymphatic metastasis (Figure 6C and Supplementary Figure 1A).